Nova Eye Medical Limited
ELXMF
$0.10
-$0.086-46.24%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.76M | -1.81M | -1.04M | -1.04M | -1.83M |
| Total Depreciation and Amortization | 180.50K | 185.60K | 516.30K | 515.30K | 179.50K |
| Total Amortization of Deferred Charges | 193.90K | 199.30K | -- | -- | 283.80K |
| Total Other Non-Cash Items | 217.60K | 223.80K | -56.30K | -56.20K | 11.10K |
| Change in Net Operating Assets | -- | -- | -648.80K | -647.40K | -- |
| Cash from Operations | -1.17M | -1.20M | -1.23M | -1.23M | -1.36M |
| Capital Expenditure | -30.30K | -31.20K | -5.60K | -5.60K | -63.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -13.70K | -14.10K | 15.20K | 15.10K | -35.80K |
| Cash from Investing | -44.00K | -45.20K | 9.60K | 9.50K | -99.10K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -176.00K | -176.00K | -92.00K | -92.00K | -167.00K |
| Issuance of Common Stock | -- | -- | 3.72M | 3.72M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -114.70K | -117.90K | 2.39M | 2.38M | -108.80K |
| Foreign Exchange rate Adjustments | 55.70K | 57.30K | 700.00 | 700.00 | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.27M | -1.30M | 1.17M | 1.16M | -1.57M |